S&P 500   3,337.95 (-0.33%)
DOW   27,327.81 (-0.22%)
QQQ   271.52 (-1.14%)
AAPL   445.73 (-2.17%)
MSFT   212.14 (-1.95%)
FB   271.19 (+2.23%)
GOOGL   1,497.04 (-0.53%)
AMZN   3,170.45 (-1.69%)
NVDA   446.06 (-1.62%)
CGC   16.83 (-3.94%)
BABA   248.71 (-6.39%)
TSLA   1,439.20 (-3.38%)
MU   48.32 (-0.78%)
GE   6.40 (+0.95%)
AMD   83.63 (-3.55%)
T   29.95 (+0.37%)
F   6.86 (-1.01%)
ACB   10.09 (-2.13%)
GILD   69.12 (+0.45%)
NFLX   490.75 (-3.60%)
DIS   130.47 (-0.27%)
BAC   26.13 (+2.59%)
BA   170.50 (-0.99%)
S&P 500   3,337.95 (-0.33%)
DOW   27,327.81 (-0.22%)
QQQ   271.52 (-1.14%)
AAPL   445.73 (-2.17%)
MSFT   212.14 (-1.95%)
FB   271.19 (+2.23%)
GOOGL   1,497.04 (-0.53%)
AMZN   3,170.45 (-1.69%)
NVDA   446.06 (-1.62%)
CGC   16.83 (-3.94%)
BABA   248.71 (-6.39%)
TSLA   1,439.20 (-3.38%)
MU   48.32 (-0.78%)
GE   6.40 (+0.95%)
AMD   83.63 (-3.55%)
T   29.95 (+0.37%)
F   6.86 (-1.01%)
ACB   10.09 (-2.13%)
GILD   69.12 (+0.45%)
NFLX   490.75 (-3.60%)
DIS   130.47 (-0.27%)
BAC   26.13 (+2.59%)
BA   170.50 (-0.99%)
S&P 500   3,337.95 (-0.33%)
DOW   27,327.81 (-0.22%)
QQQ   271.52 (-1.14%)
AAPL   445.73 (-2.17%)
MSFT   212.14 (-1.95%)
FB   271.19 (+2.23%)
GOOGL   1,497.04 (-0.53%)
AMZN   3,170.45 (-1.69%)
NVDA   446.06 (-1.62%)
CGC   16.83 (-3.94%)
BABA   248.71 (-6.39%)
TSLA   1,439.20 (-3.38%)
MU   48.32 (-0.78%)
GE   6.40 (+0.95%)
AMD   83.63 (-3.55%)
T   29.95 (+0.37%)
F   6.86 (-1.01%)
ACB   10.09 (-2.13%)
GILD   69.12 (+0.45%)
NFLX   490.75 (-3.60%)
DIS   130.47 (-0.27%)
BAC   26.13 (+2.59%)
BA   170.50 (-0.99%)
S&P 500   3,337.95 (-0.33%)
DOW   27,327.81 (-0.22%)
QQQ   271.52 (-1.14%)
AAPL   445.73 (-2.17%)
MSFT   212.14 (-1.95%)
FB   271.19 (+2.23%)
GOOGL   1,497.04 (-0.53%)
AMZN   3,170.45 (-1.69%)
NVDA   446.06 (-1.62%)
CGC   16.83 (-3.94%)
BABA   248.71 (-6.39%)
TSLA   1,439.20 (-3.38%)
MU   48.32 (-0.78%)
GE   6.40 (+0.95%)
AMD   83.63 (-3.55%)
T   29.95 (+0.37%)
F   6.86 (-1.01%)
ACB   10.09 (-2.13%)
GILD   69.12 (+0.45%)
NFLX   490.75 (-3.60%)
DIS   130.47 (-0.27%)
BAC   26.13 (+2.59%)
BA   170.50 (-0.99%)
Log in

NASDAQ:RAREUltragenyx Pharmaceutical Price Target & Analyst Ratings

$84.86
+0.30 (+0.35 %)
(As of 08/7/2020 01:57 PM ET)
Add
Compare
Today's Range
$84.24
Now: $84.86
$87.76
50-Day Range
$71.49
MA: $81.13
$90.00
52-Week Range
$31.99
Now: $84.86
$91.77
Volume13,714 shs
Average Volume374,906 shs
Market Capitalization$5.14 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.21

Analyst Ratings

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Ultragenyx Pharmaceutical in the last 12 months. Their average twelve-month price target is $82.50, suggesting that the stock has a possible downside of 2.78%. The high price target for RARE is $99.00 and the low price target for RARE is $64.00. There are currently 3 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.812.812.832.73
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $82.50$81.36$76.60$73.55
Price Target Upside: 2.78% downside2.71% downside21.36% upside20.80% upside

Ultragenyx Pharmaceutical (NASDAQ:RARE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Ultragenyx Pharmaceutical (NASDAQ:RARE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/31/2020Credit Suisse GroupReiterated RatingHold$64.00Low
7/31/2020Morgan StanleyLower Price TargetOverweight$88.00 ➝ $87.00High
7/31/2020BarclaysBoost Price TargetOverweight$87.00 ➝ $99.00Low
7/28/2020JPMorgan Chase & Co.Reiterated RatingBuy$84.00High
7/2/2020Canaccord GenuityBoost Price TargetBuy$85.00 ➝ $91.00Medium
7/1/2020SunTrust BanksBoost Price Target$82.00 ➝ $88.00Medium
7/1/2020WedbushBoost Price TargetHold ➝ Outperform$83.00 ➝ $91.00High
7/1/2020Robert W. BairdBoost Price TargetOutperform$75.00 ➝ $90.00High
6/30/2020Piper SandlerBoost Price TargetOverweight$70.00 ➝ $83.00High
5/18/2020Stifel NicolausBoost Price TargetPositive ➝ Buy$70.00 ➝ $82.00High
5/8/2020CitigroupBoost Price TargetNeutral$53.00 ➝ $66.00Low
2/18/2020Evercore ISIReiterated RatingBuyLow
2/14/2020CowenReiterated RatingBuy$75.00High
1/2/2020Raymond JamesDowngradeOutperform ➝ Market PerformHigh
12/18/2019Piper Jaffray CompaniesReiterated RatingBuy$70.00High
9/4/2019SVB LeerinkReiterated RatingOutperform ➝ Positive$80.00 ➝ $85.00High
9/11/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$72.00 ➝ $94.00Low
9/2/2018JMP SecuritiesReiterated RatingBuy$94.00Medium
5/10/2018Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$63.00Medium
12/4/2017Jefferies Financial GroupUpgradeHold ➝ Buy$58.00 ➝ $72.00High
8/8/2017HC WainwrightReiterated RatingNeutral ➝ Neutral$72.00 ➝ $75.00Low
(Data available from 8/7/2018 forward)
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.